Recent

% | $
Quotes you view appear here for quick access.

ALLIQUA, INC. Message Board

  • wvwvwv12399 wvwvwv12399 Jul 25, 2013 9:06 AM Flag

    News for 'ALQA' - (Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, such as a Transdermal Patch)

    News for 'ALQA' - (Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, such as a Transdermal Patch)


    Jul 25, 2013 (ACCESSWIRE via COMTEX) -- New York - (Accesswire - July 25, 2013)
    - Alliqua, Inc. (OTCQB: ALQA), a wound management and drug delivery company, is
    making strides aiming to take advantage of the $142 billion drug delivery market
    by launching a preclinical proof-of-principal study of an experimental hydrogel
    transdermal patch containing lidocaine. The global drug delivery market is
    expected to reach $224.2 billion by the year 2017. Additionally, the global
    wound dressing market is expected to reach $6 billion by 2017.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies